LADENBURG THALMANN FINANCIAL SERVICES INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,024,000
-0.1%
17,084
-0.2%
0.01%
-14.3%
Q3 2019$1,025,000
-1.4%
17,112
+6.4%
0.01%
-12.5%
Q2 2019$1,040,000
-19.6%
16,084
+1.0%
0.01%
-20.0%
Q1 2019$1,294,000
+58.0%
15,930
+5.3%
0.01%
+42.9%
Q4 2018$819,000
-10.7%
15,133
-14.8%
0.01%
-12.5%
Q3 2018$917,000
+13.9%
17,762
-2.6%
0.01%0.0%
Q2 2018$805,0000.0%18,2400.0%0.01%0.0%
Q1 2018$805,000
-7.4%
18,240
+5.6%
0.01%0.0%
Q4 2017$869,000
-1.5%
17,267
-0.7%
0.01%
-20.0%
Q3 2017$882,000
-0.6%
17,387
-0.2%
0.01%0.0%
Q2 2017$887,000
+29.7%
17,418
+2.3%
0.01%
+11.1%
Q1 2017$684,000
-11.3%
17,034
+5.6%
0.01%
-18.2%
Q4 2016$771,000
+6.9%
16,127
-18.0%
0.01%0.0%
Q3 2016$721,000
+66.9%
19,674
+6.1%
0.01%
+57.1%
Q2 2016$432,000
-15.0%
18,540
+47.8%
0.01%
-22.2%
Q1 2016$508,000
-21.5%
12,546
+20.0%
0.01%
-25.0%
Q4 2015$647,00010,4550.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders